• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.气道微生物群与肺癌中 PI3K 通路的上调有关。
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1188-1198. doi: 10.1164/rccm.201710-2118OC.
2
Aerodigestive dysbiosis in children with chronic cough.儿童慢性咳嗽中的气消化道微生态失调。
Pediatr Pulmonol. 2018 Sep;53(9):1288-1298. doi: 10.1002/ppul.24115. Epub 2018 Jul 8.
3
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
4
Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.肺癌单侧肺叶肿块患者与对照者双侧保护性标本毛刷下呼吸道微生物组的差异。
Int J Cancer. 2018 Feb 15;142(4):769-778. doi: 10.1002/ijc.31098. Epub 2017 Nov 8.
5
Lower Airway Dysbiosis Affects Lung Cancer Progression.下呼吸道微生态失调影响肺癌进展。
Cancer Discov. 2021 Feb;11(2):293-307. doi: 10.1158/2159-8290.CD-20-0263. Epub 2020 Nov 11.
6
Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.下呼吸道微生态失调加重轻中度慢性阻塞性肺疾病肺部炎症损伤。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1101-1114. doi: 10.1164/rccm.202210-1865OC.
7
Airway Microbiota Determines Innate Cell Inflammatory or Tissue Remodeling Profiles in Lung Transplantation.气道微生物群决定肺移植中固有细胞的炎症或组织重塑特征。
Am J Respir Crit Care Med. 2016 Nov 15;194(10):1252-1263. doi: 10.1164/rccm.201512-2424OC.
8
Longitudinal Lower Airway Microbial Signatures of Acute Cellular Rejection in Lung Transplantation.肺移植中急性细胞排斥的纵向下呼吸道微生物特征。
Am J Respir Crit Care Med. 2024 Jun 15;209(12):1463-1476. doi: 10.1164/rccm.202309-1551OC.
9
Evaluation of the airway microbiome in nontuberculous mycobacteria disease.非结核分枝杆菌病气道微生物组评估。
Eur Respir J. 2018 Oct 25;52(4). doi: 10.1183/13993003.00810-2018. Print 2018 Oct.
10
Airway PI3K pathway activation is an early and reversible event in lung cancer development.气道 PI3K 通路激活是肺癌发生的早期和可逆事件。
Sci Transl Med. 2010 Apr 7;2(26):26ra25. doi: 10.1126/scitranslmed.3000251.

引用本文的文献

1
Targeting the Tumor Microbiota in Cancer Therapy Basing on Nanomaterials.基于纳米材料的癌症治疗中靶向肿瘤微生物群
Exploration (Beijing). 2025 Mar 24;5(4):e20210185. doi: 10.1002/EXP.20210185. eCollection 2025 Aug.
2
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities.非小细胞肺癌中的免疫治疗耐药性:从机制到治疗机遇
J Exp Clin Cancer Res. 2025 Aug 23;44(1):250. doi: 10.1186/s13046-025-03519-z.
3
Exploring the metabolomics and metagenomics of chronic obstructive pulmonary disease (COPD) and lung cancer: unraveling the complex interplay.探索慢性阻塞性肺疾病(COPD)和肺癌的代谢组学与宏基因组学:揭示复杂的相互作用。
J Thorac Dis. 2025 Jul 31;17(7):5268-5281. doi: 10.21037/jtd-2025-278. Epub 2025 Jul 29.
4
Dissecting the intratumoral microbiome landscape in lung cancer.剖析肺癌中的肿瘤内微生物群落景观。
Front Immunol. 2025 Jul 24;16:1614731. doi: 10.3389/fimmu.2025.1614731. eCollection 2025.
5
Worldwide Research Trends on Lung Cancer and Microbiota: A Bibliometric and Visualized Analysis.全球肺癌与微生物群的研究趋势:文献计量与可视化分析
J Multidiscip Healthc. 2025 Jul 29;18:4291-4308. doi: 10.2147/JMDH.S516036. eCollection 2025.
6
Advancements in understanding tumor-resident bacteria and their application in cancer therapy.肿瘤驻留细菌的认识进展及其在癌症治疗中的应用。
Mil Med Res. 2025 Jul 25;12(1):38. doi: 10.1186/s40779-025-00623-1.
7
The tumor microbiome in cancer progression: mechanisms and therapeutic potential.癌症进展中的肿瘤微生物群:机制与治疗潜力
Mol Cancer. 2025 Jul 15;24(1):195. doi: 10.1186/s12943-025-02403-w.
8
Coculture of tumor organoids with pathogenic microorganisms: a novel system to mimic pathogenic infection.肿瘤类器官与致病微生物的共培养:一种模拟致病感染的新系统。
Front Cell Infect Microbiol. 2025 Jun 30;15:1601688. doi: 10.3389/fcimb.2025.1601688. eCollection 2025.
9
Gut microbiota and tuberculosis infection: interaction and therapeutic potential.肠道微生物群与结核病感染:相互作用及治疗潜力
Gut Microbes. 2025 Dec;17(1):2531201. doi: 10.1080/19490976.2025.2531201. Epub 2025 Jul 14.
10
Distinct Lung Adenocarcinoma-Associated Microbiota Are Associated with Inflammatory Immune Landscapes and Tumor Cell Proliferation via LCIIAR-ISG15 Regulatory Networks.不同的肺腺癌相关微生物群通过LCIIAR-ISG15调控网络与炎症免疫景观和肿瘤细胞增殖相关。
Cancer Manag Res. 2025 Jul 4;17:1315-1328. doi: 10.2147/CMAR.S520098. eCollection 2025.

本文引用的文献

1
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.卡那单抗抑制白细胞介素-1β对动脉粥样硬化患者肺癌发病的影响:一项随机、双盲、安慰剂对照试验的探索性结果。
Lancet. 2017 Oct 21;390(10105):1833-1842. doi: 10.1016/S0140-6736(17)32247-X. Epub 2017 Aug 27.
2
Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.吸入干扰素-γ治疗的特发性肺纤维化患者的肺部微生物群与宿主免疫状态
ERJ Open Res. 2017 Jul 12;3(3). doi: 10.1183/23120541.00008-2017. eCollection 2017 Jul.
3
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
4
Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions.肺癌患者与良性肿块样病变患者支气管肺泡灌洗液体内微生物群的特征比较
Lung Cancer. 2016 Dec;102:89-95. doi: 10.1016/j.lungcan.2016.10.016. Epub 2016 Oct 31.
5
Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome.脓毒症和急性呼吸窘迫综合征中肠道细菌对肺部微生物组的富集。
Nat Microbiol. 2016 Jul 18;1(10):16113. doi: 10.1038/nmicrobiol.2016.113.
6
A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.一项关于肌醇在患有支气管发育异常的吸烟者中的随机IIb期试验。
Cancer Prev Res (Phila). 2016 Dec;9(12):906-914. doi: 10.1158/1940-6207.CAPR-15-0254. Epub 2016 Sep 22.
7
Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.口腔分类群使肺部微生物组富集与 Th17 表型的肺部炎症有关。
Nat Microbiol. 2016 Apr 4;1:16031. doi: 10.1038/nmicrobiol.2016.31.
8
Helminth infection promotes colonization resistance via type 2 immunity.蠕虫感染通过2型免疫促进定植抗性。
Science. 2016 Apr 29;352(6285):608-12. doi: 10.1126/science.aaf3229. Epub 2016 Apr 14.
9
Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study.吸烟者与非吸烟者中慢性阻塞性肺疾病的患病率和发病率:鹿特丹研究
Eur J Epidemiol. 2016 Aug;31(8):785-92. doi: 10.1007/s10654-016-0132-z. Epub 2016 Mar 5.
10
Discovery and validation of potential bacterial biomarkers for lung cancer.肺癌潜在细菌生物标志物的发现与验证
Am J Cancer Res. 2015 Sep 15;5(10):3111-22. eCollection 2015.

气道微生物群与肺癌中 PI3K 通路的上调有关。

Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.

机构信息

1 Division of Pulmonary and Critical Care Medicine.

2 Flatiron Institute, Center for Computational Biology, Simons Foundation, New York, New York.

出版信息

Am J Respir Crit Care Med. 2018 Nov 1;198(9):1188-1198. doi: 10.1164/rccm.201710-2118OC.

DOI:10.1164/rccm.201710-2118OC
PMID:29864375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6221574/
Abstract

RATIONALE

In lung cancer, upregulation of the PI3K (phosphoinositide 3-kinase) pathway is an early event that contributes to cell proliferation, survival, and tissue invasion. Upregulation of this pathway was recently described as associated with enrichment of the lower airways with bacteria identified as oral commensals.

OBJECTIVES

We hypothesize that host-microbe interactions in the lower airways of subjects with lung cancer affect known cancer pathways.

METHODS

Airway brushings were collected prospectively from subjects with lung nodules at time of diagnostic bronchoscopy, including 39 subjects with final lung cancer diagnoses and 36 subjects with noncancer diagnoses. In addition, samples from 10 healthy control subjects were included. 16S ribosomal RNA gene amplicon sequencing and paired transcriptome sequencing were performed on all airway samples. In addition, an in vitro model with airway epithelial cells exposed to bacteria/bacterial products was performed.

MEASUREMENTS AND MAIN RESULTS

The composition of the lower airway transcriptome in the patients with cancer was significantly different from the control subjects, which included up-regulation of ERK (extracellular signal-regulated kinase) and PI3K signaling pathways. The lower airways of patients with lung cancer were enriched for oral taxa (Streptococcus and Veillonella), which was associated with up-regulation of the ERK and PI3K signaling pathways. In vitro exposure of airway epithelial cells to Veillonella, Prevotella, and Streptococcus led to upregulation of these same signaling pathways.

CONCLUSIONS

The data presented here show that several transcriptomic signatures previously identified as relevant to lung cancer pathogenesis are associated with enrichment of the lower airway microbiota with oral commensals.

摘要

背景

在肺癌中,PI3K(磷酸肌醇 3-激酶)途径的上调是导致细胞增殖、存活和组织侵袭的早期事件。最近有研究表明,该途径的上调与富含被鉴定为口腔共生菌的下气道有关。

目的

我们假设肺癌患者下气道中的宿主-微生物相互作用会影响已知的癌症途径。

方法

前瞻性地从诊断性支气管镜检查时患有肺结节的患者中收集气道刷检标本,包括 39 例最终诊断为肺癌的患者和 36 例非癌症诊断的患者。此外,还纳入了 10 例健康对照者的样本。对所有气道样本进行 16S 核糖体 RNA 基因扩增子测序和配对转录组测序。此外,还进行了气道上皮细胞暴露于细菌/细菌产物的体外模型实验。

测量和主要结果

癌症患者下气道转录组的组成与对照组有显著差异,包括 ERK(细胞外信号调节激酶)和 PI3K 信号通路的上调。肺癌患者的下气道富含口腔分类群(链球菌和韦荣球菌),这与 ERK 和 PI3K 信号通路的上调有关。体外暴露于气道上皮细胞的韦荣球菌、普雷沃氏菌和链球菌导致这些相同的信号通路上调。

结论

本文提供的数据表明,先前被认为与肺癌发病机制相关的几个转录组特征与富含口腔共生菌的下气道微生物群有关。